Feasibility and Safety of Nintedanib in Combination With Nivolumab in Pretreated Patients With Advanced or Metastatic NSCLC of Adenocarcinoma Histology
Clinical trial NCT04046614 · COMPLETED
Trial details
- NCT number
- NCT04046614
- Sponsor
- AIO-Studien-gGmbH
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-25
- Primary completion
- 2023-05-23
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.